Citadel Advisors
PASG icon

Citadel Advisors’s Passage Bio PASG Stock Holding History

Citadel Advisors’s Portfolio PASG Stock Details PASG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-17,660
Closed -$208K – 13886
2025
Q4 		$208K Sell
17,660
-1,431
-7% -$12.4K ﹤0.01% 10959
2025
Q3 		$153K Buy
19,091
+6,707
+54% +$46.7K ﹤0.01% 11517
2025
Q2 		$99.1K Buy
+12,384
New +$90.5K ﹤0.01% 11352
2024
Q4 		– Sell
-20,126
Closed -$282K – 15141
2024
Q3 		$282K Buy
20,126
+12,213
+154% +$194K ﹤0.01% 9465
2024
Q2 		$126K Sell
7,913
-3,165
-29% -$77.4K ﹤0.01% 10588
2024
Q1 		$299K Sell
11,078
-4,508
-29% -$108K ﹤0.01% 9456
2023
Q4 		$315K Buy
15,586
+10,411
+201% +$144K ﹤0.01% 9064
2023
Q3 		$68.1K Buy
5,175
+853
+20% +$14K ﹤0.01% 11358
2023
Q2 		$81.4K Buy
4,322
+1,273
+42% +$25.2K ﹤0.01% 11228
2023
Q1 		$58.4K Sell
3,049
-1,522
-33% -$41.3K ﹤0.01% 11955
2022
Q4 		$126K Sell
4,571
-5,513
-55% -$139K ﹤0.01% 10870
2022
Q3 		$252K Sell
10,084
-9,144
-48% -$360K ﹤0.01% 9956
2022
Q2 		$908K Buy
19,228
+6,868
+56% +$321K ﹤0.01% 7232
2022
Q1 		$767K Buy
12,360
+8,604
+229% +$709K ﹤0.01% 8334
2021
Q4 		$477K Buy
3,756
+1,431
+62% +$234K ﹤0.01% 9811
2021
Q3 		$463K Sell
2,325
-756
-25% -$180K ﹤0.01% 10063
2021
Q2 		$816K Sell
3,081
-30,703
-91% -$9.5M ﹤0.01% 8895
2021
Q1 		$11.8M Buy
+33,784
New +$14.4M ﹤0.01% 2736
2020
Q4 		– Sell
-932
Closed -$245K – 11363
2020
Q3 		$245K Sell
932
-215
-19% -$74K ﹤0.01% 8476
2020
Q2 		$627K Buy
1,147
+510
+80% +$229K ﹤0.01% 6664
2020
Q1 		$200K Buy
+637
New +$199K ﹤0.01% 8015

Other funds holding PASG

LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
YCM
Yiheng Capital Management San Francisco, California $231M AUM 29.07% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Citadel Advisors's PASG Position: Q1 2026 in Review

Citadel Advisors sold out of Passage Bio (PASG) in Q1 2026, closing a stake of 17,660 shares — an estimated $208K sold.

Citadel Advisors first reported a position in PASG in Q1 2020 and held it in 21 quarters. The position peaked at $11.8M in Q1 2021. 35 funds tracked by Wall St. Rank hold PASG as of Q1 2026.

  • Citadel Advisors reported no remaining Passage Bio position as of Q1 2026 after selling out during the quarter.
  • Citadel Advisors sold 17,660 Passage Bio shares in Q1 2026, an estimated $208K.
  • Citadel Advisors first reported a position in Passage Bio in Q1 2020 and held it in 21 quarters.
  • Citadel Advisors's Passage Bio position peaked at $11.8M in Q1 2021.
  • 35 funds tracked by Wall St. Rank held Passage Bio as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.